Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms

Journal of Investigative Dermatology

Volumn 112, Issue 2, 1999, Pages 165-170

  Ma, Yongsheng ^a   Longley, B Jack ^a   Wang, Xiaomei ^a   Blount, John L ^b   Langley, Keith ^c   Caughey, George H ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMGEN INC   (United States)

Author keywords

c KIT; In situ; Mastocytosis; Receptor tyrosine kinase; Stem cell factor

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; DNA SEQUENCE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE INSERTION; GENE SEQUENCE; MASTOCYTOMA; MUTATION RATE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; ONCOGENE C KIT; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0032948780     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00488.x     Document Type: Article

References (45)

1. Altschul SF, Gish W, Miller W, Myers EM, Lipman DJ: Basic local alignment search tool. J Mol Biol 215:403-410, 1990
2. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, et al: Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 10:4121-4128, 1991
3. Brizzi MF, Zini MG, Aronica MG, et al: Convergence of signaling by interleukin- 3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase. J Biol Chem 269:31680-31684, 1994
4. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res 12:345-355, 1988
5. Cohen D, Reif JS, Brodey RS, Keiser H: Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res 34:2859-2868, 1974
6. DeVinney R, Gold WV: Establishment of two dog mastocytoma cell lines in continuous culture. Am J Respir Cell Mol Biol 3:413-420, 1990
7. Furitsu T, Tsujimura T, Tono T, et al: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736- 1744, 1993
8. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1-96, 1994
9. Hirota S, Isozaki K, Moriyama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
10. Hottendorf GH, Nielsen SW: Canine mastocytoma - a review of clinical aspects. J Am Vet Med Assoc 154:917-924, 1969
11. Kitayama H, Kanakura Y, Furitsu T, et al: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790- 798, 1995
12. Kondoh G, Hayasaka N, Li Q, Nishimune Y, Hakaura A: An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis. Oncogene 10:341-347, 1995
13. Lazarus SC, DeVinney R, McCabe LJ, Finkbeiner WE, Elias DJ, Gold WM: Isolated canine mastocytoma cells: propagation and characterization of two cell lines. Am J Physiol 251:C935-C944, 1986
14. Lev S, Yarden Y, Givol D: Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J Biol Chem 267: 15970-15977, 1992
15. Linnekin D, DeBerry CS, Mou S: Lyn associates with the juxtamemebrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. J Biol Chem 272:27450-27455, 1997
16. Lishner M, Confino-Cohen R, Mekori YA, et al: Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J Allergy Clin Immunol 98:199-204, 1996
17. Longley J, Ding T, Cuono C, et al: Isolation, detection, and amplification of intact mRNA from dermatome strips, epidermal sheets, and sorted epidermal cells. J Invest Dermatol 97:974-979, 1991
18. Longley J, Duffy TP, Kohn S: The mast cell and mast cell disease. J Am Acad Dermatol 32:545-561, 1995
19. Longley BJ, Tyrrell L, Lu S, et al: Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature Genet 12:312-314, 1996
20. Longley BJ, Tyrrell L, Ma Y, et al: Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 94:9017-9021, 1997
21. Macy DW, MacEwen EG. Mast cell tumors. In: Withrow SJ, MacEwen EG (eds). Clinical Veterinary Oncology. Philadelphia: J.B. Lippincott, 1989, pp. 156-166
22. Majumder S, Brown K, Qui F, Besmer P: c-kit protein, a transmembrane kinase: identification in tissues and characterization. Mol Cell Biol 8:4896-4903, 1988
23. Martin FH, Suggs SV, Langley KE, et al: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203-211, 1990
24. Mohammadi M, Schlessinger J, Hubbard SR: Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86:577-587, 1996
25. Moriyama Y, Tsujimura T, Hashimoto K, et al: Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase. J Biol Chem 271: 3347-3350, 1996
26. Nagata H, Worobec AS, Oh CK, et al: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92:10560-10564, 1995
27. Nocka K, Majumder S, Chabot B, et al: Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816-826, 1989
28. 41 and W. EMBO J 9:1805-1813, 1990
29. Peitsch MC: ProMod and Swiss-Model: internal-based tools for automated comparative protein modeling. Biochem Soc Trans 24:274-279, 1996
30. 568/570 of the activated c-KIT in megakaryocites. J Biol Chem 272:5915-5920, 1997
31. Priester WA: Skin tumors in domestic animals: data from 21 US and Canadian colleges of veterinary medicine. J Natl Cancer Inst 50:457-466, 1973
32. Qiu F, Ray P, Brown K, et al: Primary structure of c-kit: relationship with the CSF- 1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003-1011, 1988
33. Reith AD, Ellis C, Lyman SD, et al: Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J 10:2451- 2459, 1991
34. Serve H, Hsu YC, Besmer P: Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. J Biol Chem 269:6026- 6030, 1994
35. Serve H, Yee NS, Stella G, et al: Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J 14:473-483, 1995
36. Shull RM, Suggs SV, Langley KE, et al: Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture. Exp Hematol 20:1118-1124, 1992
37. Sicheri F, Moarefi I, Kuriyan J: Crystal structure of the Src family tyrosine kinase Hck. Nature 385:602-609, 1997
38. Tsujimura T, Furitsu T, Morimoto M, et al: Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619-2626, 1994
39. Tsujimura T, Furitsu T, Morimoto M, et al: Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 106:377-385, 1995
40. Tsujimura T, Morimoto M, Hashimoto K, et al: Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood 87:273-283, 1996
41. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990
42. Xu W, Harrison SC, Eck MJ: Three-dimensional structure of the tyrosine kinase c-Src. Nature 385:595-602, 1997
43. Yarden Y, Kuang W-J, Yang-Feng T, et al: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341- 3351, 1987
44. Yee NS, Langen H, Besmer P: Mechanism of kit ligand, phorbol ester, and calcium- induced down-regulation of c-kit receptors in mast cells. J Biol Chem 268:14189- 14201, 1993
45. Yee NS, Hsiau CM, Serve H, Vosseller K, Besmer P: Mechanism of down-regulation of c-kit receptor. J Biol Chem 269:31991-31998, 1994